1. Home
  2. BLCO vs MTH Comparison

BLCO vs MTH Comparison

Compare BLCO & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • MTH
  • Stock Information
  • Founded
  • BLCO 1853
  • MTH 1985
  • Country
  • BLCO Canada
  • MTH United States
  • Employees
  • BLCO N/A
  • MTH N/A
  • Industry
  • BLCO Ophthalmic Goods
  • MTH Homebuilding
  • Sector
  • BLCO Health Care
  • MTH Consumer Discretionary
  • Exchange
  • BLCO Nasdaq
  • MTH Nasdaq
  • Market Cap
  • BLCO 4.9B
  • MTH 5.1B
  • IPO Year
  • BLCO 2022
  • MTH 1988
  • Fundamental
  • Price
  • BLCO $15.23
  • MTH $77.20
  • Analyst Decision
  • BLCO Hold
  • MTH Buy
  • Analyst Count
  • BLCO 11
  • MTH 9
  • Target Price
  • BLCO $15.80
  • MTH $86.88
  • AVG Volume (30 Days)
  • BLCO 492.5K
  • MTH 901.3K
  • Earning Date
  • BLCO 10-29-2025
  • MTH 10-28-2025
  • Dividend Yield
  • BLCO N/A
  • MTH 2.24%
  • EPS Growth
  • BLCO N/A
  • MTH N/A
  • EPS
  • BLCO N/A
  • MTH 8.78
  • Revenue
  • BLCO $4,891,000,000.00
  • MTH $6,216,250,000.00
  • Revenue This Year
  • BLCO $8.27
  • MTH N/A
  • Revenue Next Year
  • BLCO $5.73
  • MTH $6.59
  • P/E Ratio
  • BLCO N/A
  • MTH $8.75
  • Revenue Growth
  • BLCO 8.81
  • MTH N/A
  • 52 Week Low
  • BLCO $10.45
  • MTH $59.27
  • 52 Week High
  • BLCO $21.69
  • MTH $106.99
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 59.83
  • MTH 49.78
  • Support Level
  • BLCO $15.00
  • MTH $77.85
  • Resistance Level
  • BLCO $15.50
  • MTH $81.22
  • Average True Range (ATR)
  • BLCO 0.34
  • MTH 2.12
  • MACD
  • BLCO 0.02
  • MTH -0.34
  • Stochastic Oscillator
  • BLCO 72.03
  • MTH 17.81

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

Share on Social Networks: